BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

AFCAGRO

All Eps Dividend Board Agm Q1 Q2 Q3

AFCAGRO 21-Nov-2021

(Continuation news of AFCAGRO): 4. The company has made significant related party transaction without complying BSEC Notification No. SEC/CMRRCD/2006-159/Admin/02-10 dated September 10, 2006. & SEC/CMRRCD/2008-183/Admin/03-30 dated June 1, 2009. 5. As disclosed in note no. 17.01 of notes to the financial statements, the company paid Tk. 33,425,000 to it's workers but the Section 242- in regard to Investment of Participation Fund of the Bangladesh Labour (cont.5)

AFCAGRO 21-Nov-2021

(Continuation news of AFCAGRO): that an asset may be impaired. If any such indication exists, the entity shall estimate the recoverable amount of the asset. But the company did not provide any information regarding the assessment of any indication of impairment. 3. Cash at banks includes some uncleared cheques amounting to Tk. 31,667,699 which are shown in the reconciliation statements as "uncleared lodgement" but till our reporting date those cheques were not cleared. (cont.4)

AFCAGRO 21-Nov-2021

(Continuation news of AFCAGRO): No proper disclosure has been made in accordance with Para 46 & Para 81(c) of IAS-12 the company did not comply with VAT & Tax related provisions/sections of ITO ordinance 1984 and VAT & SD Act-2012 including compliance of IAS-12 by virtue of above gazette notification of commerce ministry & above SRO from NBR. 2. According to Para-9 of IAS-36, An Entity shall assess at the end of each reporting period whether there is any indication (cont.3)

AFCAGRO 21-Nov-2021

(Continuation news of AFCAGRO): captioned "National Active Pharmaceutical Ingredients (API) & Laboratory Reagents Production and Export Policy" in regard to tax exemption against which relevant S.R.O. No-316-Act/Income Tax/2021 dated 11 October, 2021 from National Board of Revenue (NBR) has obtained by the company. But some conditions of said SRO has yet to be complied with by the company to make effective Tax exemption. (cont.2)

AFCAGRO 21-Nov-2021

The auditor of the AFC Agro Biotech Ltd has given the "Qualified Opinion" & "Emphasis of matter" paragraphs in the Auditor's Report for the year ended on 30 June, 2021. Basis for Qualified Opinion: 1. Provision for current income tax and deferred tax required as per Para 12 & 15 of IAS 12 has not been made except for other income, as disclosed in note # 14 & 16, based on gazette No- 26.00.0000.100.42.008.17-54 dated 14-05-2018 by Commerce Ministry under the (cont.1)

AFCAGRO 31-Oct-2021

There will be no price limit on the trading of the shares of the Company today (31.10.2021) following its corporate declaration.

AFCAGRO 31-Oct-2021

(Cont. of AFCAGRO): Date of AGM: December 23, 2021, Time: 9:30 AM, Venue: Digital Platform. Record Date: November 28, 2021. The Company has reported EPS of Tk. 0.15, NAV per share of Tk. 18.00 and NOCFPS of Tk. 0.17 for the year ended on June 30, 2021 as against Tk. 0.32 Tk. 17.85 and Tk. 2.28 respectively for the same period of the previous year.(end)

AFCAGRO 31-Oct-2021

The Board of Directors has recommended 0.50% Cash dividend (other than Sponsors and Directors) for the year ended on June 30, 2021. Total paid up number of shares is 115,216,200 nos. and General Shareholders holding is 80,317,213 nos. of shares and Directors are holding 34,898,987 nos. of shares. Taka 4,015,860.65 will be payable as dividend. (cont.)

AFCAGRO 26-Oct-2021

The Company has informed that Memorandum of Understanding has been signed between The Centre for Advanced Research in Sciences and AFC Agro Biotech Limited, JND Biotech and Emergent Biotech (Two USA Biotech Company) on Covid-19 vaccine (titled as DUBD-Vac) and other infectious diseases related research & development under the proposed "Biotechnology Research Collaboration".

AFCAGRO 21-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 12:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

Previous Next page